FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at therapy of tuberculosis. What is used is a combination of formula (I), (S)-N-[[3-[3-fluor-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-xazolidinyl]methyl]cetamide, or a pharmaceutically acceptable salt thereof in combination with at least two agents, for preparing a therapeutic agent for treating tuberculosis after the individual has undergone the initial therapeutic phase.
EFFECT: use of the declared group of inventions provides a high therapeutic effect of treating tebrculosis.
12 tbl, 8 ex, 10 cl
| Title | Year | Author | Number |
|---|---|---|---|
| SANFETRINEM OR ITS SALT OR COMPLEX ESTER FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTION | 2018 |
|
RU2757272C2 |
| METHOD OF OBTAINING POLY-DL-LACTIDE-CO-GLYCOLIDE NANOPARTICLES WITH INCAPSULATED IN THEM ANTITUBERCULOSIS MEDICATIONS | 2005 |
|
RU2396945C2 |
| ANTI-TUBERCULOSIS COMPOSITION, CONTAINING OXAZOLE COMPOUNDS | 2006 |
|
RU2434632C2 |
| ANTITUBERCULOSIS COMPOSITION, CONTAINING OXAZOLE COMPOUNDS | 2011 |
|
RU2560676C2 |
| ANTITUBERCULOSIS REMEDY | 2017 |
|
RU2756208C2 |
| PHENOTHIAZINE DERIVATIVES AND THEIR USE AGAINST TUBERCULOSIS | 2013 |
|
RU2663289C2 |
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN FORM OF DISPERSIBLE TABLET CONTAINING GRANULATED ISONIAZID AND GRANULATED RIFAPENTINE, AND METHOD FOR PREPARING IT | 2014 |
|
RU2694056C2 |
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION | 2014 |
|
RU2682178C2 |
| METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
| THIAZOLINO-2-PYRIDONES WITH CONDENSED RINGS IN COMBINATION WITH A DRUG AGAINST TUBERCULOSIS | 2018 |
|
RU2791467C2 |
